These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 18679757

  • 1. 11C-methionine-PET for evaluation of carbon ion radiotherapy in patients with pelvic recurrence of rectal cancer.
    Koizumi M, Saga T, Yoshikawa K, Suzuki K, Yamada S, Hasebe M, Ohashi S, Abd-Elrazek S, Ishikawa H, Sagou K, Tamura K, Hara R, Kato H, Yasuda S, Yanagi T, Tsujii H.
    Mol Imaging Biol; 2008; 10(6):374-80. PubMed ID: 18679757
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of 11C-methionine-PET for predicting the efficacy of carbon ion radiation therapy for head and neck mucosal malignant melanoma.
    Hasebe M, Yoshikawa K, Nishii R, Kawaguchi K, Kamada T, Hamada Y.
    Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1220-1228. PubMed ID: 28535963
    [Abstract] [Full Text] [Related]

  • 3. A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET.
    Hasebe M, Yoshikawa K, Ohashi S, Toubaru S, Kawaguchi K, Sato J, Mizoe J, Tsujii H.
    Mol Imaging Biol; 2010 Oct; 12(5):554-62. PubMed ID: 20369300
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of methionine-PET in predicting the efficacy of heavy-particle therapy on primary adenoid cystic carcinomas of the head and neck.
    Toubaru S, Yoshikawa K, Ohashi S, Tanimoto K, Hasegawa A, Kawaguchi K, Saga T, Kamada T.
    Radiat Oncol; 2013 Jun 13; 8():143. PubMed ID: 23758795
    [Abstract] [Full Text] [Related]

  • 5. [(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy.
    Zhang H, Yoshikawa K, Tamura K, Tomemori T, Sagou K, Tian M, Kandatsu S, Kamada T, Tsuji H, Suhara T, Suzuki K, Tanada S, Tsujii H.
    Clin Cancer Res; 2004 Mar 01; 10(5):1764-72. PubMed ID: 15014030
    [Abstract] [Full Text] [Related]

  • 6. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
    Yanagawa T, Saito K, Kiyohara H, Ohno T, Nakano T, Takagishi K.
    Radiat Oncol; 2015 Dec 21; 10():259. PubMed ID: 26691334
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pre-operative staging with positron emission tomography in patients with pelvic recurrence of rectal cancer.
    Faneyte IF, Dresen RC, Edelbroek MA, Nieuwenhuijzen GA, Rutten HJ.
    Dig Surg; 2008 Dec 21; 25(3):202-7. PubMed ID: 18577865
    [Abstract] [Full Text] [Related]

  • 9. Re-irradiation With Carbon Ion Radiotherapy for Pelvic Rectal Cancer Recurrences in Patients Previously Irradiated to the Pelvis.
    Barcellini A, Vitolo V, Cobianchi L, Peloso A, Vanoli A, Mirandola A, Facoetti A, Fiore MR, Iannalfi A, Vischioni B, Cuccia F, Ronchi S, Bonora M, Riva G, Petrucci R, D'Ippolito E, Mas FD, Preda L, Valvo F.
    In Vivo; 2020 Dec 21; 34(3):1547-1553. PubMed ID: 32354961
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic value of post-treatment metabolic tumor volume from 11C-methionine PET/CT in recurrent malignant glioma.
    Jung TY, Min JJ, Bom HS, Jung S, Kim IY, Lim SH, Kim DY, Kwon SY.
    Neurosurg Rev; 2017 Apr 21; 40(2):223-229. PubMed ID: 27282449
    [Abstract] [Full Text] [Related]

  • 13. [11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma.
    Reske SN, Moritz S, Kull T.
    Q J Nucl Med Mol Imaging; 2012 Oct 21; 56(5):430-9. PubMed ID: 23069922
    [Abstract] [Full Text] [Related]

  • 14. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
    Kitajima K, Murphy RC, Nathan MA, Froemming AT, Hagen CE, Takahashi N, Kawashima A.
    J Nucl Med; 2014 Feb 21; 55(2):223-32. PubMed ID: 24434294
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of clinical outcomes between carbon ion radiotherapy and X-ray radiotherapy for reirradiation in locoregional recurrence of rectal cancer.
    Chung SY, Takiyama H, Kang JH, Chang JS, Min BS, Tsuji H, Yamada S, Koom WS.
    Sci Rep; 2022 Feb 03; 12(1):1845. PubMed ID: 35115612
    [Abstract] [Full Text] [Related]

  • 17. 11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.
    Tomura N, Saginoya T, Goto H.
    J Comput Assist Tomogr; 2018 Feb 03; 42(4):517-521. PubMed ID: 29613985
    [Abstract] [Full Text] [Related]

  • 18. Positron emission tomography for prostate, bladder, and renal cancer.
    Schöder H, Larson SM.
    Semin Nucl Med; 2004 Oct 03; 34(4):274-92. PubMed ID: 15493005
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
    Incerti E, Fodor A, Mapelli P, Fiorino C, Alongi P, Kirienko M, Giovacchini G, Busnardo E, Gianolli L, Di Muzio N, Picchio M.
    J Nucl Med; 2015 Dec 03; 56(12):1836-42. PubMed ID: 26405166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.